Elevance Health Inc.

(New York Stock Exchange)

Top News rankings and signal summaries are processed using AI and may contain errors.

21
Somewhat Bearish -25

Elevance Health Inc (ELV) — MCH Advisory Research

Earnings report AI-generated analysis

MCH Advisory Research maintains a HOLD rating on Elevance Health (ELV) with a 12-month probability-weighted target price of $371, representing an -8% downside from the current spot price of $402. The firm's triangulated fair value sits at $326 (-19%), driven by a conservative intrinsic DCF...

Bullish Signals

  • Narrow moat from BCBS scale and Carelon growth.
  • Trades at discount to peers, implying multiple expansion.

Bearish Signals

  • Stock trades 19% rich vs. DCF anchor.
  • Medical cost spike risks earnings severely.
  • $22.2B net debt limits buybacks and adds risk.
  • Cash flow converts at only 76% of income.
  • Medicaid redeterminations strip members and pressure margins.
22
Slightly Bullish +25

Elevance Health (ELV) Stock Forecast & Price Target (2026)

AI-generated analysis

Elevance Health (ELV) is currently trading at $419.17 as of September 15, 2026, with technical indicators showing the stock above its 50-day average and an RSI in neutral territory. Financial analysts maintain a consensus price target of $457.00, representing a fair value approximately 9% higher...

Bullish Signals

  • Insiders bought $5.1M vs $3.7M sales, signaling conviction.
  • Exceeded EPS estimates by 19.97% in Q2 2026.
  • Analysts maintain Buy ratings with median target of $457.
  • Stock trades above 50-day average at $397.60.

Bearish Signals

  • Revenue estimates project a year-over-year decline of approximately 2.00%.
  • Performance lags S&P 500 benchmark with $10k investment worth $34,119 vs $35,344.
23
Somewhat Bearish -25

Elevance Health stock falls amid sector worries over rising medical costs

AI-generated analysis

Elevance Health stock declined by more than 2 percent intraday on September 9, 2026, as managed care insurers retreated amid sector-wide concerns over elevated medical expenses. The selling pressure was driven by a broader risk-off session where investors rotated out of health insurers following warnings...

Bullish Signals

  • Elevance Health reported double-digit growth in revenue and earnings per share for the second quarter of 2026 compared to the prior year.
  • Strong financial results from its commercial and government businesses indicate ongoing expansion despite recent sector-wide selling pressure.

Bearish Signals

  • Stock fell >2% amid sector retreat over high medical costs.
  • Guidance assumes stable utilization; risks if claims inflation accelerates.
  • Shares weighed down by rising yields and inflation worries.
24
Bullish +75

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here’s how

AI-generated analysis

Centene Corporation reported its first-quarter earnings in late April, revealing a counterintuitive financial story where the health insurer shed approximately 2 million members of its Affordable Care Act marketplace—reducing enrollment from 5.6 million to 3.6 million over the last year—while simultaneously generating $1.5 billion in...

Bullish Signals

  • Centene posted $1.5B net earnings in Q1.
  • Company raised full-year profit guidance.
  • Adjusted EPS jumped to $3.37, beating estimates.
  • Revenue grew 46.6B to 49.9B year-over-year.
  • Health Benefit Ratio of 75.3% beat expectations.

Bearish Signals

  • Centene lost 2 million ACA customers in one year.
  • Expired subsidies caused adverse selection forcing higher premiums.
  • Marketplace could shrink up to 26% by year-end.
  • Subsidies vanish with just $1 over 400% federal poverty level.
  • Insurers faced high claims and unfavorable member mix in 2025.
25
Somewhat Bullish +45

Elevance Health (ELV) Stock Looks Reasonable After Raised Earnings Outlook

Earnings report Financial outlook AI-generated analysis

Elevance Health (ELV) shares have appreciated 33.6% over the past year, prompting investors to assess whether current earnings power justifies the valuation. The company recently raised its longer-term earnings outlook and highlighted potential improvements in Medicaid margins, which could enhance the durability and predictability of...

Bullish Signals

  • Management lifted longer-term earnings outlook.
  • Stock trades at 18.1x P/E vs sector 25.3x.
  • Carelon programs show 10% cost savings.
  • Home-based services expand to new markets.

Bearish Signals

  • Utilization issues may limit projected medical cost savings.
  • Lawsuit highlights risk controls despite sector discount.